spiramycin to reduce placental transmission of toxoplasmosis and showed a trend toward lower transmission with PY/SA, although it did not reach statistical significance, possibly because of a lack of statistical power [ 70 ].
← all excerpts
Long-Term Outcomes in Children with Congenital Toxoplasmosis-A Systematic Review.
1
—
—